Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling.

Koelink PJ, Bloemendaal FM, Li B, Westera L, Vogels EWM, van Roest M, Gloudemans AK, van 't Wout AB, Korf H, Vermeire S, Te Velde AA, Ponsioen CY, D'Haens GR, Verbeek JS, Geiger TL, Wildenberg ME, van den Brink GR.

Gut. 2019 Sep 10. pii: gutjnl-2019-318264. doi: 10.1136/gutjnl-2019-318264. [Epub ahead of print]

2.

Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity.

Zhang XS, Li J, Krautkramer KA, Badri M, Battaglia T, Borbet TC, Koh H, Ng S, Sibley RA, Li Y, Pathmasiri W, Jindal S, Shields-Cutler RR, Hillmann B, Al-Ghalith GA, Ruiz VE, Livanos A, van 't Wout AB, Nagalingam N, Rogers AB, Sumner SJ, Knights D, Denu JM, Li H, Ruggles KV, Bonneau R, Williamson RA, Rauch M, Blaser MJ.

Elife. 2018 Jul 25;7. pii: e37816. doi: 10.7554/eLife.37816.

3.

Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease.

Koelink PJ, Wildenberg ME, Stitt LW, Feagan BG, Koldijk M, van 't Wout AB, Atreya R, Vieth M, Brandse JF, Duijst S, Te Velde AA, D'Haens GRAM, Levesque BG, van den Brink GR.

J Crohns Colitis. 2018 Jun 28;12(7):794-803. doi: 10.1093/ecco-jcc/jjy035.

4.

Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies.

Jones HG, Ritschel T, Pascual G, Brakenhoff JPJ, Keogh E, Furmanova-Hollenstein P, Lanckacker E, Wadia JS, Gilman MSA, Williamson RA, Roymans D, van 't Wout AB, Langedijk JP, McLellan JS.

PLoS Pathog. 2018 Mar 6;14(3):e1006935. doi: 10.1371/journal.ppat.1006935. eCollection 2018 Mar.

5.

DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner.

Booiman T, Loukachov VV, van Dort KA, van 't Wout AB, Kootstra NA.

PLoS One. 2015 Dec 7;10(12):e0144229. doi: 10.1371/journal.pone.0144229. eCollection 2015.

6.

Phosphodiesterase 8a supports HIV-1 replication in macrophages at the level of reverse transcription.

Booiman T, Cobos Jiménez V, van Dort KA, van 't Wout AB, Kootstra NA.

PLoS One. 2014 Oct 8;9(10):e109673. doi: 10.1371/journal.pone.0109673. eCollection 2014.

7.

The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression.

Gijsbers EF, van Sighem A, Harskamp AM, Welkers MR, de Wolf F, Brinkman K, Prins JM, Schuitemaker H, van 't Wout AB, Kootstra NA.

PLoS One. 2013 Oct 1;8(10):e76255. doi: 10.1371/journal.pone.0076255. eCollection 2013.

8.

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Rotger M, Glass TR, Junier T, Lundgren J, Neaton JD, Poloni ES, van 't Wout AB, Lubomirov R, Colombo S, Martinez R, Rauch A, Günthard HF, Neuhaus J, Wentworth D, van Manen D, Gras LA, Schuitemaker H, Albini L, Torti C, Jacobson LP, Li X, Kingsley LA, Carli F, Guaraldi G, Ford ES, Sereti I, Hadigan C, Martinez E, Arnedo M, Egaña-Gorroño L, Gatell JM, Law M, Bendall C, Petoumenos K, Rockstroh J, Wasmuth JC, Kabamba K, Delforge M, De Wit S, Berger F, Mauss S, de Paz Sierra M, Losso M, Belloso WH, Leyes M, Campins A, Mondi A, De Luca A, Bernardino I, Barriuso-Iglesias M, Torrecilla-Rodriguez A, Gonzalez-Garcia J, Arribas JR, Fanti I, Gel S, Puig J, Negredo E, Gutierrez M, Domingo P, Fischer J, Fätkenheuer G, Alonso-Villaverde C, Macken A, Woo J, McGinty T, Mallon P, Mangili A, Skinner S, Wanke CA, Reiss P, Weber R, Bucher HC, Fellay J, Telenti A, Tarr PE; MAGNIFICENT Consortium; INSIGHT; Swiss HIV Cohort Study.

Clin Infect Dis. 2013 Jul;57(1):112-21. doi: 10.1093/cid/cit196. Epub 2013 Mar 26.

9.

Reconstructing the dynamics of HIV evolution within hosts from serial deep sequence data.

Poon AF, Swenson LC, Bunnik EM, Edo-Matas D, Schuitemaker H, van 't Wout AB, Harrigan PR.

PLoS Comput Biol. 2012;8(11):e1002753. doi: 10.1371/journal.pcbi.1002753. Epub 2012 Nov 1.

10.

Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics.

van Manen D, van 't Wout AB, Schuitemaker H.

Retrovirology. 2012 Aug 24;9:70. doi: 10.1186/1742-4690-9-70. Review.

11.

HIV-1 envelope diversity 1 year after seroconversion predicts subsequent disease progression.

Rachinger A, Kootstra NA, Gijsbers EF, van den Kerkhof TL, Schuitemaker H, van 't Wout AB.

AIDS. 2012 Jul 31;26(12):1517-22. doi: 10.1097/QAD.0b013e328354f539.

PMID:
22555160
12.

HIV-1 disease progression is associated with bile-salt stimulated lipase (BSSL) gene polymorphism.

Stax MJ, Kootstra NA, van 't Wout AB, Tanck MW, Bakker M, Pollakis G, Paxton WA.

PLoS One. 2012;7(3):e32534. doi: 10.1371/journal.pone.0032534. Epub 2012 Mar 6.

13.

Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia.

Bol SM, Booiman T, van Manen D, Bunnik EM, van Sighem AI, Sieberer M, Boeser-Nunnink B, de Wolf F, Schuitemaker H, Portegies P, Kootstra NA, van 't Wout AB.

PLoS One. 2012;7(2):e30990. doi: 10.1371/journal.pone.0030990. Epub 2012 Feb 7.

14.

The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.

Edo-Matas D, Rachinger A, Setiawan LC, Boeser-Nunnink BD, van 't Wout AB, Lemey P, Schuitemaker H.

Virology. 2012 Jan 5;422(1):70-80. doi: 10.1016/j.virol.2011.10.005. Epub 2011 Nov 1.

15.

Polymorphism in HIV-1 dependency factor PDE8A affects mRNA level and HIV-1 replication in primary macrophages.

Bol SM, Booiman T, Bunnik EM, Moerland PD, van Dort K, Strauss JF 3rd, Sieberer M, Schuitemaker H, Kootstra NA, van 't Wout AB.

Virology. 2011 Nov 10;420(1):32-42. doi: 10.1016/j.virol.2011.08.013. Epub 2011 Sep 13.

16.

Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control.

van Manen D, Gras L, Boeser-Nunnink BD, van Sighem AI, Maurer I, Mangas Ruiz MM, Harskamp AM, Steingrover R, Prins JM, de Wolf F, van 't Wout AB, Schuitemaker H; Dutch HIV monitoring foundation HIV-1 Host Genetics study.

AIDS. 2011 Nov 28;25(18):2217-26. doi: 10.1097/QAD.0b013e32834bec9c.

PMID:
21860345
17.

Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course.

van Manen D, Delaneau O, Kootstra NA, Boeser-Nunnink BD, Limou S, Bol SM, Burger JA, Zwinderman AH, Moerland PD, van 't Slot R, Zagury JF, van 't Wout AB, Schuitemaker H.

PLoS One. 2011;6(7):e22208. doi: 10.1371/journal.pone.0022208. Epub 2011 Jul 21.

18.

Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing.

Bunnik EM, Swenson LC, Edo-Matas D, Huang W, Dong W, Frantzell A, Petropoulos CJ, Coakley E, Schuitemaker H, Harrigan PR, van 't Wout AB.

PLoS Pathog. 2011 Jun;7(6):e1002106. doi: 10.1371/journal.ppat.1002106. Epub 2011 Jun 23.

19.

Low incidence of HIV-1 superinfection even after episodes of unsafe sexual behavior of homosexual men in the Amsterdam Cohort Studies on HIV Infection and AIDS.

Rachinger A, Manyenga P, Burger JA, Derks van de Ven TL, Stolte IG, Prins M, van 't Wout AB, Schuitemaker H.

J Infect Dis. 2011 Jun 1;203(11):1621-8. doi: 10.1093/infdis/jir164.

PMID:
21592992
20.

Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages.

Bol SM, Moerland PD, Limou S, van Remmerden Y, Coulonges C, van Manen D, Herbeck JT, Fellay J, Sieberer M, Sietzema JG, van 't Slot R, Martinson J, Zagury JF, Schuitemaker H, van 't Wout AB.

PLoS One. 2011 Feb 25;6(2):e17190. doi: 10.1371/journal.pone.0017190.

21.

Clinical significance of HIV-1 coreceptor usage.

Schuitemaker H, van 't Wout AB, Lusso P.

J Transl Med. 2011 Jan 27;9 Suppl 1:S5. doi: 10.1186/1479-5876-9-S1-S5. Review.

22.

Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models.

Edo-Matas D, Lemey P, Tom JA, Serna-Bolea C, van den Blink AE, van 't Wout AB, Schuitemaker H, Suchard MA.

Mol Biol Evol. 2011 May;28(5):1605-16. doi: 10.1093/molbev/msq326. Epub 2010 Dec 6.

23.

Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection.

Edo-Matas D, van Gils MJ, Bowles EJ, Navis M, Rachinger A, Boeser-Nunnink B, Stewart-Jones GB, Kootstra NA, van 't Wout AB, Schuitemaker H.

Virology. 2010 Sep 30;405(2):492-504. doi: 10.1016/j.virol.2010.06.029. Epub 2010 Jul 17.

24.

Absence of HIV-1 superinfection 1 year after infection between 1985 and 1997 coincides with a reduction in sexual risk behavior in the seroincident Amsterdam cohort of homosexual men.

Rachinger A, Stolte IG, van de Ven TD, Burger JA, Prins M, Schuitemaker H, van 't Wout AB.

Clin Infect Dis. 2010 May 1;50(9):1309-15. doi: 10.1086/651687.

PMID:
20367230
25.

Evaluation of pre-screening methods for the identification of HIV-1 superinfection.

Rachinger A, van de Ven TD, Burger JA, Schuitemaker H, van 't Wout AB.

J Virol Methods. 2010 May;165(2):311-7. doi: 10.1016/j.jviromet.2010.02.016. Epub 2010 Feb 21.

PMID:
20178816
26.

Evidence for limited genetic compartmentalization of HIV-1 between lung and blood.

Heath L, Fox A, McClure J, Diem K, van 't Wout AB, Zhao H, Park DR, Schouten JT, Twigg HL, Corey L, Mullins JI, Mittler JE.

PLoS One. 2009 Sep 14;4(9):e6949. doi: 10.1371/journal.pone.0006949.

27.

Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays.

Coakley E, Reeves JD, Huang W, Mangas-Ruiz M, Maurer I, Harskamp AM, Gupta S, Lie Y, Petropoulos CJ, Schuitemaker H, van 't Wout AB.

Antimicrob Agents Chemother. 2009 Nov;53(11):4686-93. doi: 10.1128/AAC.00229-09. Epub 2009 Aug 17.

28.

HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study.

Gottlieb GS, Heath L, Nickle DC, Wong KG, Leach SE, Jacobs B, Gezahegne S, van 't Wout AB, Jacobson LP, Margolick JB, Mullins JI.

J Infect Dis. 2008 Apr 1;197(7):1011-5. doi: 10.1086/529206.

29.

Isolation and propagation of HIV-1 on peripheral blood mononuclear cells.

van 't Wout AB, Schuitemaker H, Kootstra NA.

Nat Protoc. 2008;3(3):363-70. doi: 10.1038/nprot.2008.3.

PMID:
18323807
30.

Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates.

Terpstra FG, van 't Wout AB, Schuitemaker H, van Engelenburg FA, Dekkers DW, Verhaar R, de Korte D, Verhoeven AJ.

Transfusion. 2008 Feb;48(2):304-13. Epub 2007 Nov 19.

PMID:
18028277
31.

Use of Immunological and Viral Parameters to Predict Progression of HIV Infection During Natural Course and Antiretroviral Treatment.

Koot M, van 't Wout AB, Miedema F, Schuitemaker H.

BioDrugs. 1997 Oct;8(4):243-9. No abstract available.

PMID:
18020516
32.

Resistance of surface-dried virus to common disinfection procedures.

Terpstra FG, van den Blink AE, Bos LM, Boots AG, Brinkhuis FH, Gijsen E, van Remmerden Y, Schuitemaker H, van 't Wout AB.

J Hosp Infect. 2007 Aug;66(4):332-8. Epub 2007 Jun 29.

PMID:
17601636
33.

Viral safety of C1-inhibitor NF.

Terpstra FG, Kleijn M, Koenderman AH, Over J, van Engelenburg FA, Schuitemaker H, van 't Wout AB.

Biologicals. 2007 Jun;35(3):173-81. Epub 2006 Oct 30.

PMID:
17071103
34.

T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates.

Quakkelaar ED, Beaumont T, van Nuenen AC, van Alphen FP, Boeser-Nunnink BD, van 't Wout AB, Schuitemaker H.

Virology. 2007 Mar 1;359(1):92-104. Epub 2006 Oct 18.

35.

A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.

Jensen MA, Coetzer M, van 't Wout AB, Morris L, Mullins JI.

J Virol. 2006 May;80(10):4698-704.

36.

Gene expression profiling of HIV-1 infection using cDNA microarrays.

van 't Wout AB.

Methods Mol Biol. 2005;304:455-9.

PMID:
16061997
37.

Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells.

van 't Wout AB, Swain JV, Schindler M, Rao U, Pathmajeyan MS, Mullins JI, Kirchhoff F.

J Virol. 2005 Aug;79(15):10053-8.

38.

Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.

Jensen MA, Li FS, van 't Wout AB, Nickle DC, Shriner D, He HX, McLaughlin S, Shankarappa R, Margolick JB, Mullins JI.

J Virol. 2003 Dec;77(24):13376-88.

39.

Predicting HIV-1 coreceptor usage with sequence analysis.

Jensen MA, van 't Wout AB.

AIDS Rev. 2003 Apr-Jun;5(2):104-12. Review.

PMID:
12876899
40.

Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines.

van 't Wout AB, Lehrman GK, Mikheeva SA, O'Keeffe GC, Katze MG, Bumgarner RE, Geiss GK, Mullins JI.

J Virol. 2003 Jan;77(2):1392-402.

41.

Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs.

Ichikawa JK, Norris A, Bangera MG, Geiss GK, van 't Wout AB, Bumgarner RE, Lory S.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9659-64.

42.

Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays.

Geiss GK, Bumgarner RE, An MC, Agy MB, van 't Wout AB, Hammersmark E, Carter VS, Upchurch D, Mullins JI, Katze MG.

Virology. 2000 Jan 5;266(1):8-16.

43.

Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.

van Rij RP, Portegies P, Hallaby T, Lange JM, Visser J, de Roda Husman AM, van 't Wout AB, Schuitemaker H.

J Infect Dis. 1999 Sep;180(3):854-7.

PMID:
10438379
44.

Efficient inhibition of both syncytium-inducing and non-syncytium-inducing wild-type HIV-1 by lamivudine in vivo.

van 't Wout AB, Ran LJ, Nijhuis M, Tijnagel JM, de Groot T, van Leeuwen R, Boucher CA, Schuitemaker H, Schuurman R.

AIDS. 1998 Jul 9;12(10):1169-76.

PMID:
9677166
46.

Temporal relationship between human immunodeficiency virus type 1 RNA levels in serum and cellular infectious load in peripheral blood.

Blaak H, de Wolf F, van 't Wout AB, Pakker NG, Bakker M, Goudsmit J, Schuitemaker H.

J Infect Dis. 1997 Nov;176(5):1383-7.

PMID:
9359744
47.

Changes in cellular virus load and zidovudine resistance of syncytium-inducing and non-syncytium-inducing human immunodeficiency virus populations under zidovudine pressure: a clonal analysis.

van 't Wout AB, de Jong MD, Kootstra NA, Veenstra J, Lange JM, Boucher CA, Schuitemaker H.

J Infect Dis. 1996 Oct;174(4):845-9.

PMID:
8843227
48.
49.

Envelope V2 configuration and HIV-1 phenotype: clarification.

Schuitemaker H, Fouchier RA, Broersen S, Groenink M, Koot M, van 't Wout AB, Huisman HG, Tersmette M, Miedema F.

Science. 1995 Apr 7;268(5207):115. No abstract available.

PMID:
7755774
50.

Serum levels of circulating anodic antigen and circulating cathodic antigen detected in mice infected with Schistosoma japonicum or S. mansoni.

Van 't Wout AB, De Jonge N, Wood SM, Van Lieshout L, Mitchell GF, Deelder AM.

Parasitol Res. 1995;81(5):434-7.

PMID:
7501644

Supplemental Content

Loading ...
Support Center